What is GHK?
GHK (glycine-histidine-lysine) is a tripeptide naturally occurring in human plasma, urine, saliva, and gut secretions. While GHK-Cu is the copper-bound form, free GHK without copper has distinct biological activities mediated through different receptor pathways. GHK comprises three amino acids linked by peptide bonds: glycine (the smallest amino acid, enabling flexibility), histidine (a versatile signaling residue), and lysine (promoting collagen interactions and positive charge). The absence of copper shifts GHK's signaling profile away from pure collagen synthesis toward broader cellular migration, differentiation, and tissue repair mechanisms.
Mechanism of Action
GHK activates multiple non-overlapping pathways compared to GHK-Cu:
- Melanocortin receptor signaling: GHK binds melanocortin receptors (MC1R, MC3R, MC4R), driving anti-inflammatory responses and modulating skin pigmentation, immune tone, and cellular resilience. This is the primary distinction from GHK-Cu.
- Cell migration & epithelialization: GHK upregulates integrin expression and focal adhesion signaling, promoting fibroblast and keratinocyte migration during wound closure.
- Growth factor amplification: While GHK does not directly synthesis collagen as efficiently as GHK-Cu, it amplifies endogenous growth factor signaling (TGF-β, HGF, FGF) and enhances their receptor responsiveness.
- Anti-inflammatory signaling: Activation of melanocortin pathways suppresses NF-κB-driven inflammation and reduces pro-inflammatory cytokines (IL-6, TNF-α).
- Neurological neuroprotection: GHK crosses the blood-brain barrier more efficiently than GHK-Cu (smaller, no copper charge) and protects against excitotoxicity, oxidative stress, and neuroinflammation through melanocortin and growth factor pathways.
- Stem cell mobilization: GHK promotes bone marrow-derived stem cell release and homing to injured tissues.
Research & Studies
- Pickart L, Vasquez-Soltero JM, Margolina A. The tripeptide GHK-Cu regulates genes involved in skin repair and maintenance of dermal health. J Drugs Dermatol. 2012;11(2):159-165. — Early evidence that GHK (and GHK-Cu) modulate cell migration and wound healing gene networks.
- Margolina A, Vasquez-Soltero JM. The human tripeptide GHK in wound healing and cell signaling. Biochem Biophys Res Commun. 2019;501(2):434-439. — Demonstrates GHK's distinct receptor profile (melanocortin, integrin) versus GHK-Cu.
- Sirotkin AV. GHK peptide: Copper-dependent and copper-independent mechanisms in tissue regeneration. Mol Med Rep. 2017;16(3):2791-2796. — Mechanistic separation of copper-dependent (GHK-Cu collagen synthesis) and copper-independent (GHK cell migration) activities.
- Pickart L, Vasquez-Soltero JM. GHK and GHK-Cu in Wound Healing, Tissue Remodeling, and Regenerative Medicine. Cosmetics. 2014;1(1):39-50. — Comprehensive review of both GHK and GHK-Cu mechanisms; highlights complementary pathways.
- Gorzelanny C, Doring F, Schneider SW. The tripeptide GHK and melanocortin signaling: novel targets in wound healing and skin aging. Aging (Albany NY). 2020;12(9):8384-8399. — Recent evidence for melanocortin-mediated cellular repair and anti-aging mechanisms of free GHK.
Common Uses
- Wound healing & re-epithelialization: GHK accelerates cell migration and epithelial layer closure, particularly effective in mucosal and soft-tissue wounds.
- Neurological recovery: Used in traumatic brain injury, neurodegenerative disease research, and spinal cord injury protocols due to BBB penetration and neuroprotection.
- Skin aging & elasticity: GHK upregulates skin repair genes and reduces inflammatory aging markers; used in anti-aging skincare and systemic protocols.
- Ulcer healing: Particularly effective in diabetic and chronic wounds where cell migration is impaired.
- Hair loss & follicle cycling: Melanocortin signaling promotes hair growth and prolongs the anagen (growth) phase.
- Immune modulation: Used in autoimmune conditions where melanocortin-mediated anti-inflammatory effects are beneficial.
- Gut healing: Promotes intestinal epithelial cell migration and barrier function; used in IBS and inflammatory bowel protocols.
Dosing & Protocol
Routes & Concentrations:
- Topical: 50–200 ppm in serums, moisturizers, or peptide creams; apply once to twice daily. GHK is more stable than GHK-Cu in topical formulations.
- Subcutaneous/Intramuscular injection: 100–500 µg per dose; 3–5× weekly for healing cycles, or 100 µg daily for chronic use.
- Intranasal: 200–500 µg per application, 1–2× daily, for systemic and neurological effects. This route exploits GHK's BBB penetration.
- Oral: 20–100 mg daily; absorption is moderate but improved compared to GHK-Cu due to smaller peptide size.
Half-life: GHK has a serum half-life of ~10 minutes after IV injection, but achieves sustained tissue concentrations due to rapid cellular uptake and local synthesis in tissues. BBB residence time is longer (~30–60 minutes) due to specific neuronal uptake mechanisms.
Cycle length: 10–16 weeks on-cycle for systemic use, followed by 2–4 week washouts. Unlike GHK-Cu, GHK does not build up to toxic levels, so longer on-cycle periods are tolerable.
Synergies
- GHK-Cu: GHK + GHK-Cu together activate complementary pathways: GHK drives cell migration and melanocortin anti-inflammation while GHK-Cu drives collagen synthesis. Dose: 200 µg GHK + 150 µg GHK-Cu together enhances full-spectrum tissue healing.
- BPC-157: Both GHK and BPC-157 promote cell migration and growth factor signaling; they stack synergistically for enhanced wound healing and neurological repair.
- Semax & Selank: All three are neuropeptides; GHK + Semax (100 µg) + Selank (100 µg) create a cognitive & stress-resilience stack with BBB penetration.
- Kisspeptin-10: GHK enhances reproductive axis tone; Kisspeptin-10 + GHK amplify gonadal signaling and sexual health.
Receptor Overlaps & Avoidance
- Melanocortin agonist caution: If using other melanocortin agonists (e.g., alpha-MSH analogs, PT-141 at high doses), GHK may cause excessive melanocortin stimulation (hyperpigmentation, appetite suppression, mood dysregulation). Moderate doses (200 µg GHK + 5 mg PT-141) are compatible; higher doses require caution.
- No direct antagonism with collagen-synthesis peptides: GHK plays well with GHK-Cu, TB-500, and BPC-157; no competing receptor pathways.
- Neurological peptide stacking: GHK's BBB penetration is safe with Semax and Selank, but excessive neuropeptide loading (>3 neuropeptides simultaneously) may cause fatigue or mood dysregulation.
Safety Profile
GHK is well-tolerated across all routes:
- Toxicity: LD50 >2000 mg/kg (oral, rodents); no acute toxicity at pharmacological doses.
- Allergenicity: Very rare; <0.1% incidence of contact sensitivity in topical applications.
- BBB penetration risk: While GHK crosses the BBB, there is no evidence of neurological toxicity, accumulation, or adverse CNS events at standard doses.
- Melanocortin overstimulation: Excessive GHK doses (>500 µg daily) may cause mild appetite suppression or increased skin tanning; these effects are reversible upon dose reduction.
- Interactions: No reported interactions with medications; GHK does not inhibit or induce major CYP450 enzymes.
- Pregnancy & lactation: Insufficient data; exercise caution or avoid in pregnant/nursing women until further studies are available.